Circulating donor-derived cell-free DNA as a marker for rejection after lung transplantation
Authors:
Open Access
- 11 October 2023
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 14, 1263389
Abstract
Objective: Recently, circulating donor-derive cell free DNA (dd-cfDNA) has gained growing attention in the field of solid organ transplantation. The aim of the study was to analyze circulating dd-cfDNA levels in graft rejection, ACR and AMR separately for each rejection type compared with non-rejection, and assessed the diagnostic potential of dd-cfDNA levels in predicting graft rejection after lung transplantation.Methods: A systematic search for relevant articles was conducted on Medline, Web of Science, China National Knowledge Infrastructure (CNKI), and Wanfang databases without restriction of languages. The search date ended on June 1, 2023. STATA software was used to analyze the difference between graft rejection, ACR, AMR and stable controls, and evaluate the diagnostic performance of circulating dd-cfDNA in detecting graft rejection.Results: The results indicated that circulating dd-cfDNA levels in graft rejection, ACR, and AMR were significantly higher than non-rejection (graft rejection: SMD=1.78, 95% CI: 1.31-2.25, I2 = 88.6%, P< 0.001; ACR: SMD=1.03, 95% CI: 0.47-1.59, I2 = 89.0%, P < 0.001; AMR: SMD= 1.78, 95% CI: 1.20-2.35, I2 = 89.8%, P < 0.001). Circulating dd-cfDNA levels distinguished graft rejection from non-rejection with a pooled sensitivity of 0.87 (95% CI: 0.80-0.92) and a pooled specificity of 0.82 (95% CI: 0.76-0.86). The corresponding SROC yield an AUROC of 0.90 (95% CI: 0.87-0.93).Conclusion: Circulating dd-cfDNA could be used as a non-invasive biomarker to distinguish the patients with graft rejection from normal stable controls.Systematic Review Registration: https://www.crd.york.ac.uk/prospero/, identifier CRD42023440467.Keywords
This publication has 46 references indexed in Scilit:
- Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort studyPLOS Medicine, 2017
- Rapid detection of donor cell free DNA in lung transplant recipients with rejections using donor-recipient HLA mismatchHuman Immunology, 2017
- Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile rangeStatistical Methods in Medical Research, 2016
- Noninvasive monitoring of infection and rejection after lung transplantationProceedings of the National Academy of Sciences, 2015
- Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile rangeBMC Medical Research Methodology, 2014
- HRCT Features of Acute Rejection in Patients With Bilateral Lung Transplantation: The Usefulness of Lesion DistributionTransplantation Proceedings, 2014
- Acute antibody-mediated rejection after lung transplantationThe Journal of Heart and Lung Transplantation, 2013
- Universal noninvasive detection of solid organ transplant rejectionProceedings of the National Academy of Sciences, 2011
- Surveillance Bronchoscopy in Lung Transplant Recipients: Risk versus BenefitThe Journal of Heart and Lung Transplantation, 2008
- Limited Utility of Endomyocardial Biopsy in the First Year after Heart TransplantationTransplantation, 2008